Ligand profile
1YP
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4030 — DNA topoisomerase IV, B subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
1YP- PDB
4lpb- UniProt (similar protein)
Q8DQB5- Target protein
- VK055_4030
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 138.7
- −1 ≤ LogP ≤ 5 3.77
- MW ≤ 500 Da 477.4
- LogP ≤ 5 3.77
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 138.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCNC(=O)Nc1cc(c(cn1)c2cc(cnc2)C3=NNC(=O)O3)c4nc(cs4)C(F)(F)FCCNC(=O)Nc1cc(c(cn1)c2cc(cnc2)C3=NNC(=O)O3)c4nc(cs4)C(F)(F)F
InChI=1S/C19H14F3N7O3S/c1-2-24-17(30)27-14-4-11(16-26-13(8-33-16)19(20,21)22)12(7-25-14)9-3-10(6-23-5-9)15-28-29-18(31)32-15/h3-8H,2H2,1H3,(H,29,31)(H2,24,25,27,30)InChI=1S/C19H14F3N7O3S/c1-2-24-17(30)27-14-4-11(16-26-13(8-33-16)19(20,21)22)12(7-25-14)9-3-10(6-23-5-9)15-28-29-18(31)32-15/h3-8H,2H2,1H3,(H,29,31)(H2,24,25,27,30)
VIHKUWHFUWMXKJ-UHFFFAOYSA-NVIHKUWHFUWMXKJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02518
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 1YP →
- PDB RCSB structure 4lpb →
- UniProt UniProt Q8DQB5 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “1YP”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4030.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 18
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).